Experimental: cALD HR-D (High-Risk, Regimen D)
See intervention descriptions.
Biological: Stem Cell Transplantation
Infusion given on Day 0
Drug: IMD Preparative Regimen
- Anti-thymocyte Globulin (ATG)
- Fludarabine
- Busulfan
Drug: cALD HR-D (High-Risk, Regimen D)
N-acetylcysteine, celecoxib, vitamin E and alpha lipoic acid start day of admission (prior to conditioning regimen) and continue through day +100
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
